ArticleACS central science2019

High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles.

Kin Man Au et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.